MMP9 and colorectal carcinoma: In this report, we demonstrated that antibody-mediated inhibition of MMP9 reduced primary tumor growth and metastatic lesions in an orthotopic xenograft model of CRC, and we were also able to interrogate the efficacy of targeting tumor-derived and stroma-derived MMP9 either singly or in combination.